Get Live Data

SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Egetis Therapeu Share Price
  4. Egetis Therapeu Share Regulatory News

Pin to quick picksEgetis Therapeu Regulatory News (0ABW)

Egetis Therapeu Information

Share Price Information for Egetis Therapeu (0ABW)

Share Price is delayed by 15 minutes
Get Live Data
5.64    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
0ABW Live PriceLast checked at - London Stock Exchange

Intraday Egetis Therapeu Share Chart

  • This share is an international stock.
Date   Source Headline
29th May 20269:00 amMFNEgetis Therapeutics: Change in the number of shares and votes in Egetis Therapeutics
30th Apr 20267:05 amMFNEgetis Therapeutics: Change in the number of shares and votes in Egetis Therapeutics
29th Apr 20265:00 amMFNEgetis Therapeutics: Interim report Q1 2026
21st Apr 20268:57 pmMFNEgetis Therapeutics: Egetis Therapeutics has successfully carried out a directed share issue amounting to SEK 350 million (approximately USD 38 million)
21st Apr 20263:31 pmMFNEgetis Therapeutics: Egetis Therapeutics announces the intention to carry out a directed share issue of approximately SEK 350 million (approximately USD 38 million)
14th Apr 20261:45 pmMFNBulletin from Egetis Therapeutics’ Annual General Meeting 2026
27th Mar 20263:42 pmMFNEgetis Announces FDA Acceptance and Priority Review of NDA for Emcitate® (tiratricol) for MCT8 Deficiency
24th Mar 20262:05 pmMFNEgetis Therapeutics’ Annual Report 2025 published
12th Mar 202611:02 amRNSNOTICE OF ANNUAL GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL)
12th Mar 202611:02 amMFNNOTICE OF ANNUAL GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL)
26th Feb 20266:00 amMFNYear-End Report January-December 2025
29th Jan 20266:00 amMFNEgetis Completes the U.S. Rolling NDA Submission for Emcitate® (tiratricol) for Treatment of MCT8 Deficiency
30th Dec 20257:00 amMFNChange in the number of ordinary shares and votes in Egetis Therapeutics
19th Dec 20256:00 amRNSEgetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency
19th Dec 20256:00 amMFNEgetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency
25th Nov 20256:00 amMFNInterim report Q3 2025
14th Nov 20256:00 amMFNEgetis announces positive results from the ReTRIACt study of Emcitate® (tiratricol) in MCT8 deficiency

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
GI41
Citi Fun 30
LSE
0.00%
SE52
Eig Pearl 46 A
LSE
0.00%
WN64
Mitsu Hc Cap 27
LSE
0.00%
RF07
Nat Bk Can 27 A
LSE
0.00%
LL61
Citi Fun 26
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-43.75%
MPAL
Medpal AI
LSE
33.87%
NANO
Nanoco
LSE
18.64%
ITM
Itm Power
LSE
8.98%
UKOG
UK Oil & Gas
LSE
-2.56%